Parcion Private Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Parcion Private Wealth’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$262K	Sell	4,579 -2,768	-38%	-$152K	0.01%	422
2026 Q1	$415K	Buy	7,347 +270	+4%	+$15.7K	0.03%	276
2025 Q4	$421K	Buy	+7,077	New	+$385K	0.03%	263
2025 Q3	–	Sell	-7,038	Closed	-$387K	–	360
2025 Q2	$387K	Buy	7,038 +2,340	+50%	+$138K	0.03%	200
2025 Q1	$332K	Buy	+4,698	New	+$316K	0.03%	206

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Parcion Private Wealth's BMRN Position: Q2 2026 in Review

Parcion Private Wealth reduced its BioMarin Pharmaceuticals (BMRN) stake by 38% in Q2 2026, selling an estimated $152K and leaving 4,579 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #422.

Parcion Private Wealth first reported a position in BMRN in Q1 2025 and has held it in 5 quarters since. The position peaked at $421K in Q4 2025. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

Parcion Private Wealth held 4,579 shares of BioMarin Pharmaceuticals worth $262K as of Q2 2026.
Parcion Private Wealth sold 2,768 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $152K.
BioMarin Pharmaceuticals made up 0.01% of Parcion Private Wealth's portfolio in Q2 2026, its #422 holding.
Parcion Private Wealth first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
Parcion Private Wealth's BioMarin Pharmaceuticals position peaked at $421K in Q4 2025.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Parcion Private Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.